| Literature DB >> 28725181 |
Csaba Vastagh1, Zsolt Liposits1,2.
Abstract
The antero-ventral periventricular zone (AVPV) and medial preoptic area (MPOA) have been recognized as gonadal hormone receptive regions of the rodent brain that-via wiring to gonadotropin-releasing hormone (GnRH) neurons-contribute to orchestration of the preovulatory GnRH surge. We hypothesized that neural genes regulating the induction of GnRH surge show altered expression in proestrus. Therefore, we compared the expression of 48 genes obtained from intact proestrous and metestrous mice, respectively, by quantitative real-time PCR (qPCR) method. Differential expression of 24 genes reached significance (p < 0.05). Genes upregulated in proestrus encoded neuropeptides (kisspeptin (KP), galanin (GAL), neurotensin (NT), cholecystokinin (CCK)), hormone receptors (growth hormone secretagogue receptor, μ-opioid receptor), gonadal steroid receptors (estrogen receptor alpha (ERα), progesterone receptor (PR), androgen receptor (AR)), solute carrier family proteins (vesicular glutamate transporter 2, vesicular monoamine transporter 2), proteins of transmitter synthesis (tyrosine hydroxylase (TH)) and transmitter receptor subunit (AMPA4), and other proteins (uncoupling protein 2, nuclear receptor related 1 protein). Proestrus evoked a marked downregulation of genes coding for adenosine A2a receptor, vesicular gamma-aminobutyric acid (GABA) transporter, 4-aminobutyrate aminotransferase, tachykinin precursor 1, NT receptor 3, arginine vasopressin receptor 1A, cannabinoid receptor 1, ephrin receptor A3 and aldehyde dehydrogenase 1 family, member L1. Immunocytochemistry was used to visualize the proteins encoded by Kiss1, Gal, Cck and Th genes in neuronal subsets of the AVPV/MPOA of the proestrous mice. The results indicate that gene expression of the AVPV/MPOA is significantly modified at late proestrus including genes that code for neuropeptides, gonadal steroid hormone receptors and synaptic vesicle transporters. These events support cellular and neuronal network requirements of the positive estradiol feedback action and contribute to preparation of the GnRH neuron system for the pre-ovulatory surge release.Entities:
Keywords: AVPV; MPOA; PCR; gene expression; immunocytochemistry; metestrus; mouse; proestrus
Year: 2017 PMID: 28725181 PMCID: PMC5495965 DOI: 10.3389/fncel.2017.00183
Source DB: PubMed Journal: Front Cell Neurosci ISSN: 1662-5102 Impact factor: 5.505
Figure 1Differentially expressed genes in the antero-ventral periventricular/medial preoptic area (MPOA) of the late proestrous mouse. Relative quantity (RQ) values indicate the relative expression of genes in the pro- vs. metestrous experimental groups (p < 0.05, Student’s t-test). RQ values are visualized as a graph with log10 scale on the y axis.
Figure 2Predicted interactions among proteins encoded by genes expressed differentially in late proestrus. Network visualization of the differentially expressed proteins was achieved by STRING v10 (http://string-db.org). The clusters of neuropeptides/neuropeptide receptors coupled to G proteins (1), solute carrier proteins involved in synaptic vesicle cycle (2) gonadal steroid hormone signaling pathway (3) are prominent.
Figure 3Immunocytochemical localization of kisspeptin (KP), galanin (GAL), cholecystokinin (CCK) and tyrosine-hydroxylase (TH) in the antero-ventral periventricular/MPA of the proestrous mouse. The uppermost row illustrates the MPA and its subdivisions in three representative rostro-caudal planes (from left to right). Red triangle indicates the border lines of tissue area sampled for the real-time PCR study. Immunofluorescent detection of KP, galanin, CCK and TH is provided in the three, representative frontal planes. KP, CCK and TH appear in cell bodies within the AVPV and the periventricular nucleus (PE) in addition to neuronal processes. Galanin-immunoreactivity is not detectable at the level of perikarya in proestrous mouse, despite its intense occurrence in axons. aca, anterior commissure; AVPV, antero-ventral periventricular nucleus; MPOM, medial division of the medial preoptic nucleus; MPOL, lateral division of the medial preoptic nucleus; OVLT, vascular organ of lamina terminalis; 3V, 3rd ventricle. Scale bar: 200 μm.
PCR analysis of genes regulated differentially in proestrus in the antero-ventral periventricular/medial preoptic area of the mouse.
| Gene symbol | Description | TaqMan ID | RQ | ± SEM | |
|---|---|---|---|---|---|
| Avpr1a | Arginine vasopressin receptor 1A | Mm00444092_m1 | 0.60 | 0.11 | 4.36E-02 |
| Cartpt | CART prepropeptide | Mm04210469_m1 | 0.78 | 0.23 | 5.83E-01 |
| Cck | Cholecystokinin | Mm00446170_m1 | 1.82 | 0.35 | 3.95E-02 |
| Gal | Galanin | Mm00439056_m1 | 6.36 | 2.29 | 5.65E-03 |
| Galr1 | Galanin receptor 1 | Mm00433515_m1 | 1.62 | 0.30 | 1.58E-01 |
| Ghsr | Growth hormone secretagogue receptor | Mm00616415_m1 | 5.00 | 1.47 | 8.00E-03 |
| Kiss1 | KiSS-1 metastasis-suppressor | Mm03058560_m1 | 58.81 | 28.43 | 1.03E-02 |
| Kiss1r | KISS1 receptor | Mm00475046_m1 | 0.89 | 0.10 | 3.93E-01 |
| Nts | Neurotensin | Mm00481140_m1 | 3.82 | 1.09 | 8.44E-03 |
| Oprm1 | Opioid receptor, mu 1 | Mm01188089_m1 | 1.82 | 0.23 | 2.02E-03 |
| Sort1 | Sortilin (neurotensin receptor 3) | Mm00490905_m1 | 0.70 | 0.07 | 1.71E-02 |
| Sstr3 | Somatostatin receptor 3 | Mm00436695_s1 | 1.12 | 0.11 | 4.28E-01 |
| Tac1 | Tachykinin precursor 1 | Mm01166996_m1 | 0.34 | 0.03 | 4.99E-02 |
| Abat | 4-aminobutyrate aminotransferase | Mm00556951_m1 | 0.77 | 0.06 | 2.03E-02 |
| Gad1 | Glutamate decarboxylase 1 | Mm04207432_g1 | 0.74 | 0.14 | 1.81E-01 |
| Gad2 | Glutamic acid decarboxylase 2 | Mm00484623_m1 | 0.93 | 0.09 | 7.42E-01 |
| Slc17a6 | solute carrier family 17 (Vesicular Glutamate Transporter), member 1 | Mm00499876_m1 | 2.06 | 0.30 | 1.83E-03 |
| Slc18a2 | Solute carrier family 18 (vesicular monoamine transporter), member 2 | Mm00553058_m1 | 3.22 | 0.791 | 1.57E-02 |
| Slc32a1 | Solute carrier family 32 (GABA vesicular transporter), member 1 | Mm00494138_m1 | 0.55 | 0.054 | 4.37E-02 |
| Th | Tyrosine hydroxylase | Mm00447557_m1 | 3.58 | 1.19 | 1.43E-02 |
| Cnr1 | Cannabinoid receptor 1 (brain) | Mm01212171_s1 | 0.67 | 0.08 | 2.31E-02 |
| Gabbr1 | Gamma-aminobutyric acid (GABA) B receptor, 1 | Mm00444578_m1 | 1.00 | 0.10 | 9.09E-01 |
| Gabra3 | Gamma-aminobutyric acid (GABA) A receptor, subunit alpha 3 | Mm01294271_m1 | 1.20 | 0.17 | 3.96E-01 |
| Gabrb3 | Gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 | Mm00433473_m1 | 1.12 | 0.14 | 5.28E-01 |
| Gria1 | Glutamate receptor, ionotropic, AMPA1 (alpha 1) | Mm00433753_m1 | 1.18 | 0.14 | 4.11E-01 |
| Gria2 | Glutamate receptor, ionotropic, AMPA2 (alpha 2) | Mm00442822_m1 | 0.91 | 0.08 | 8.04E-01 |
| Gria4 | Glutamate receptor, ionotropic, AMPA 4 | Mm00444754_m1 | 1.48 | 0.14 | 1.23E-02 |
| Grin1 | Glutamate receptor, ionotropic, NMDA1 (zeta 1) | Mm00433790_m1 | 1.24 | 0.09 | 1.29E-01 |
| Ar | Androgen receptor | Mm00442688_m1 | 1.39 | 0.21 | 3.02E-02 |
| Esr1 | Estrogen receptor 1 (alpha) | Mm00433149_m1 | 3.76 | 1.12 | 1.24E-02 |
| Esr2 | Estrogen receptor 2 (beta) | Mm00599821_m1 | 1.34 | 0.30 | 3.79E-01 |
| Gper1 | G protein-coupled estrogen receptor 1 | Mm01194815_m1 | 1.11 | 0.15 | 5.22E-01 |
| Nr4a2 | Nuclear receptor subfamily 4, group A, member 2 | Mm00443060_m1 | 2.03 | 0.28 | 4.93E-03 |
| Pgr | Progesterone receptor | Mm00435628_m1 | 2.03 | 0.28 | 1.03E-03 |
| Pgrmc1 | Progesterone receptor membrane component 1 | Mm00443985_m1 | 4.61 | 2.85 | 9.39E-02 |
| Adora2a | Adenosine A2a receptor | Mm00802075_m1 | 0.23 | 0.03 | 2.70E-02 |
| Amhr2 | Anti-Mullerian hormone type 2 receptor | Mm00513847_m1 | 0.35 | 0.14 | 4.12E-01 |
| Cxcr4 | Chemokine (C-X-C motif) receptor 4 | Mm01292123_m1 | 1.48 | 0.37 | 2.58E-01 |
| Epha3 | EPH receptor A3 | Mm00580743_m1 | 0.59 | 0.07 | 4.16E-03 |
| Gfap | Glial fibrillary acidic protein | Mm01253033_m1 | 0.71 | 0.09 | 3.64E-01 |
| Kcnc1 | Potassium voltage gated channel, Shaw-related subfamily, member 1 | Mm00657708_m1 | 0.67 | 0.16 | 1.72E-01 |
| Lepr | Leptin receptor | Mm00440181_m1 | 1.00 | 0.11 | 8.16E-01 |
| Nrxn3 | Neurexin III | Mm00553213_m1 | 1.37 | 0.26 | 3.15E-01 |
| Rab14 | RAB14, member RAS oncogene family | Mm00499577_m1 | 0.34 | 0.14 | 8.78E-01 |
| Slc1a4 | Solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 | Mm00444532_m1 | 1.17 | 0.14 | 3.40E-01 |
| Slc25a4 | Solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 | Mm01207393_m1 | 0.79 | 0.09 | 7.99E-02 |
| Ucp2 | Uncoupling protein 2 (mitochondrial, proton carrier) | Mm00627599_m1 | 1.30 | 0.08 | 1.69E-02 |
| Aldh1l1 | Aldehyde dehydrogenase 1 family, member L1 | Mm03048957_m1 | 0.74 | 0.06 | 4.79E-02 |
Forty-eight target genes were selected and grouped in neuropeptides/receptors, neurotransmitter synthesis and transport, GABA/glutamate signaling, gonadal steroid receptor signaling and others categories. Relative quantity (RQ), standard error of the mean (SEM) and p-value are given for each studied gene. Expression of 24 genes reached the level of significance (.